These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 76073)

  • 1. Serum-alpha-hydroxybutyrate dehydrogenase levels in sickle-cell disease and sickle-cell crisis.
    White JM; Billimoria F; Muller MA; Davis LR; Stroud CE
    Lancet; 1978 Mar; 1(8063):532-3. PubMed ID: 76073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-hydroxybutyrate dehydrogenase levels in children with sickle cell disease.
    Karayalcin G; Lanzkowsky P; Kari AB
    Am J Pediatr Hematol Oncol; 1981; 3(2):169-71. PubMed ID: 7304859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell crisis as evaluated from measurements of hydroxybutyrate dehydrogenase and myoglobin in plasma.
    Roth EF; Bardfeld PA; Goldsmith SJ; Radel E; Williams JC
    Clin Chem; 1981 Feb; 27(2):314-6. PubMed ID: 7460284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-alpha-hydroxybutyrate dehydrogenase in sickle-cell disease.
    Fleming AF
    Lancet; 1978 Jul; 2(8079):46. PubMed ID: 78243
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum ferritin concentration in sickle cell crisis.
    Brownell A; Lowson S; Brozović M
    J Clin Pathol; 1986 Mar; 39(3):253-5. PubMed ID: 3958215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease.
    Nduka N; Kazem Y; Saleh B
    J Clin Pathol; 1995 Jul; 48(7):648-51. PubMed ID: 7560173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-hydroxybutyrate dehydrogenase and the diagnosis of painful crisis in sickle cell anaemia.
    Akenzua GI; Ihongbe JC; Asemota HN
    Afr J Med Med Sci; 1992 Dec; 21(2):13-7. PubMed ID: 1308075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase A2 levels in acute chest syndrome of sickle cell disease.
    Styles LA; Schalkwijk CG; Aarsman AJ; Vichinsky EP; Lubin BH; Kuypers FA
    Blood; 1996 Mar; 87(6):2573-8. PubMed ID: 8630425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of sickle cell-hemoglobin C disease.
    Williams S; Maude GH; Serjeant GR
    J Pediatr; 1986 Oct; 109(4):586-9. PubMed ID: 3761071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].
    Dickerhoff R; von Ruecker A
    Klin Padiatr; 1995; 207(6):321-5. PubMed ID: 8569133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presentation, management and prevention of crisis in sickle cell disease in Africa.
    Fleming AF
    Blood Rev; 1989 Mar; 3(1):18-28. PubMed ID: 2650773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical aspects of sickle cell anemia].
    Nosny P; Perquis P
    Munch Med Wochenschr; 1966 Aug; 108(31):1533-40. PubMed ID: 6014380
    [No Abstract]   [Full Text] [Related]  

  • 13. The predictive value of white cell count in assessing clinical severity of sickle cell anaemia in Afro-Caribbeans patients.
    Olatunji PO; Davies SC
    Afr J Med Med Sci; 2000 Mar; 29(1):27-30. PubMed ID: 11379463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency-room crises in sickle-cell disease.
    Roberts GJ; Haas RA; King FM
    Lancet; 1973 Jun; 1(7818):1511. PubMed ID: 4123174
    [No Abstract]   [Full Text] [Related]  

  • 16. Is pain crisis a cause of death in sickle cell disease?
    Parfrey NA; Moore W; Hutchins GM
    Am J Clin Pathol; 1985 Aug; 84(2):209-12. PubMed ID: 4025226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sickle cell diseases. Clinical manifestations including the "sickle crisis".
    Konotey-Ahulu FI
    Arch Intern Med; 1974 Apr; 133(4):611-9. PubMed ID: 4818434
    [No Abstract]   [Full Text] [Related]  

  • 18. Perivascular fibrosis in the bone marrow in sickle cell disease.
    Manci EA; Culberson DE; Gardner JM; Brogdon BG; Shah AK; Holladay JE; Powell RW; Mankad VN
    Arch Pathol Lab Med; 2004 Jun; 128(6):634-9. PubMed ID: 15163238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
    Renoux C; Joly P; Faes C; Mury P; Eglenen B; Turkay M; Yavas G; Yalcin O; Bertrand Y; Garnier N; Cuzzubbo D; Gauthier A; Romana M; Möckesch B; Cannas G; Antoine-Jonville S; Pialoux V; Connes P
    J Pediatr; 2018 Apr; 195():228-235. PubMed ID: 29449005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered amount and activity of superoxide dismutase in sickle cell anemia.
    Schacter L; Warth JA; Gordon EM; Prasad A; Klein BL
    FASEB J; 1988 Mar; 2(3):237-43. PubMed ID: 3350236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.